ACHV · NASDAQ · Biotechnology

Achieve Life Sciences

Develops cytisinicline for nicotine dependence across smoking-cessation and vaping-cessation programs.

$8.26
After-hours close+0.15 (+1.85%)
At close$8.11(−0.86%)
DateEstimateReportedSurprise
Nov 2026−$0.20
Aug 2026−$0.16−$0.80−385.2%
May 2026−$0.30−$0.19+36.7%
Mar 2026−$0.27−$0.28−3.7%
Nov 2025−$0.24−$0.28−16.7%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Jul 2017
May 2017
Feb 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Nov 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 5, 2026−$0.20$10.6M
Aug 11, 2026−$0.16−$0.80−385.2%
May 12, 2026−$0.30−$0.19+36.7%
Mar 24, 2026−$0.27−$0.28−3.7%
Nov 6, 2025−$0.24−$0.28−16.7%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 7, 2025
May 13, 2025
Mar 11, 2025
Nov 7, 2024
Aug 13, 2024
May 9, 2024
Mar 28, 2024
Nov 9, 2023
Aug 14, 2023
May 9, 2023
Mar 16, 2023
Nov 14, 2022
Aug 11, 2022
May 12, 2022
Mar 10, 2022
Nov 9, 2021
Aug 11, 2021
May 13, 2021
Mar 11, 2021
Nov 12, 2020
Aug 6, 2020
May 14, 2020
Mar 13, 2020
Nov 6, 2019
Aug 8, 2019
May 15, 2019
Mar 14, 2019
Nov 7, 2018
Aug 8, 2018
May 9, 2018
Mar 1, 2018
Nov 9, 2017
Jul 31, 2017
May 15, 2017
Feb 23, 2017
Nov 10, 2016
Aug 4, 2016
May 12, 2016
Mar 9, 2016
Nov 12, 2015
Aug 13, 2015